A natural inhibitor of c-Met that sensitizes head and neck cancer cells resistant to EGFR and PI3K co-targeting

被引：0
|
作者：
Anisuzzaman, Asm [1 ]
Hague, Abedul [2 ]
Butler, Brian [3 ]
Amin, Arm R. [3 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Marshall Univ, Huntington, WV USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-706
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
706
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Synergistic Effects of PI3K and c-Myc Co-targeting in Acute Leukemia: Shedding New Light on Resistance to Selective PI3K-δ Inhibitor CAL-101
    Riyahi, Niknam
    Safaroghli-Azar, Ava
    Sheikh-Zeineddini, Negar
    Sayyadi, Mohamad
    Bashash, Davood
    CANCER INVESTIGATION, 2019, 37 (07) : 311 - 324
  • [32] Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells
    Adediran, Samusi
    Wang, Linbo
    Khan, Mohammad Afnan
    Guang, Wei
    Fan, Xiaoxuan
    Dan, Hancai
    Qi, Jianfei
    Jay, Steven M.
    Carrier, France
    Hussain, Arif
    CANCERS, 2022, 14 (19)
  • [33] Co-targeting PIM and PI3K/mTOR pathways with a single molecule: Novel orally available combined PIM/PI3K and PIM/PI3K/mTOR kinase inhibitors.
    Blanco Aparicio, Carmen
    Renner, Oliver
    Gomez-Casero, Elena
    Cebria, Antonio
    Ajenjo, Nuria
    Aguirre, Enara
    Cebrian, David
    Rodriguez de Miguel, Ma Carmen
    Pequeno, Belen
    Isabel Albarran, Ma
    Riesco, Rosario
    Belen Garcia, Ana
    Alvarez, Rosa
    O'Neill, Michael
    Martinez, Sonia
    Pastor, Joaquin
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [34] MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway
    Jiang, Jingjin
    Feng, Xiaoning
    Zhou, Wenjing
    Wu, Yue
    Yang, Yunmei
    ONCOTARGET, 2016, 7 (45) : 73188 - 73199
  • [35] Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2
    Keysar, Stephen B.
    Le, Phuong N.
    Miller, Bettina
    Jackson, Brian C.
    Eagles, Justin R.
    Nieto, Cera
    Kim, Jihye
    Tang, Binwu
    Glogowska, Magdalena J.
    Morton, J. Jason
    Padilla-Just, Nuria
    Gomez, Karina
    Warnock, Emily
    Reisinger, Julie
    Arcaroli, John J.
    Messersmith, Wells A.
    Wakefield, Lalage M.
    Gao, Dexiang
    Tan, Aik-Choon
    Serracino, Hilary
    Vasiliou, Vasilis
    Roop, Dennis R.
    Wang, Xiao-Jing
    Jimeno, Antonio
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [36] Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition
    Kimbung, Siker
    Biskup, Ewa
    Johansson, Ida
    Aaltonen, Kristina
    Ottosson-Wadlund, Astrid
    Gruvberger-Saal, Sofia
    Cunliffe, Heather
    Fadeel, Bengt
    Loman, Niklas
    Berglund, Pontus
    Hedenfalk, Ingrid
    CANCER LETTERS, 2012, 319 (02) : 232 - 241
  • [37] Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
    Gremke, Niklas
    Besong, Isabelle
    Stroh, Alina
    von Wichert, Luise
    Witt, Marie
    Elmshaeuser, Sabrina
    Wanzel, Michael
    Fromm, Martin F.
    Taudte, R. Verena
    Schmatloch, Sabine
    Karn, Thomas
    Reinisch, Mattea
    Hirmas, Nader
    Loibl, Sibylle
    Wuendisch, Thomas
    Litmeyer, Anne-Sophie
    Jank, Paul
    Denkert, Carsten
    Griewing, Sebastian
    Wagner, Uwe
    Stiewe, Thorsten
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [38] PI3K p110α inhibition sensitizes cervical cancer cells with aberrant PI3K signaling activation to PARP inhibitor BMN673
    Cao, Penglong
    Wang, Yingxin
    Lv, Yunyi
    Jiang, Nan
    Zhong, Lin
    Ma, Xiaolu
    Xiao, Xiaoguang
    Ding, Dapeng
    Gu, Juebin
    Lin, Lin
    Li, Shijun
    ONCOLOGY REPORTS, 2019, 42 (05) : 2097 - 2107
  • [39] Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells
    Oleg Chen
    Friederike Manig
    Loreen Lehmann
    Nagwa Sorour
    Steffen Löck
    Zhanru Yu
    Anna Dubrovska
    Michael Baumann
    Benedikt M. Kessler
    Oleh Stasyk
    Leoni A. Kunz-Schughart
    Cellular and Molecular Life Sciences, 2021, 78 : 3021 - 3044
  • [40] Dual PI3K/mTOR Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer
    Yasumizu, Yota
    Miyajima, Akira
    Kosaka, Takeo
    Miyazaki, Yasumasa
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2014, 191 (01): : 227 - 234
12345